Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15

Histological grading and staging of chronic hepatitis.

Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290 · see citing works

Mapping mendelian factors underlying quantitative traits using RFLP linkage maps.

Lander, E. S., & Botstein, D. (1989) · Genetics · doi:10.1093/genetics/121.1.185 · Cited by 5,236 · see citing works

Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

Lander, E. S., & Kruglyak, L. (1995) · Nature Genetics · doi:10.1038/ng1195-241 · Cited by 5,196 · see citing works

Chronic hepatitis B

Lok, A. S.-F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,092 · see citing works

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011 · see citing works

Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury

Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,090 · see citing works

A simple regression method for mapping quantitative trait loci in line crosses using flanking markers

Haley, C. S., & Knott, S. A. (1992) · Heredity · doi:10.1038/hdy.1992.131 · Cited by 1,991 · see citing works

The Liver: Biology and Pathobiology.

(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-690_3 · Cited by 1,615 · see citing works

The burden of selected digestive diseases in the United States

Sandler, R. S., Everhart, J. E., Donowitz, M., Adams, E., Cronin, K., Goodman, C., Gemmen, E., Shah, S., Avdic, A., & Rubin, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32978 · Cited by 1,512 · see citing works

An Update on Terminology and Reporting

Batts, K. P., & Ludwig, J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199512000-00007 · Cited by 1,082 · see citing works

Interval mapping of multiple quantitative trait loci.

Jansen, R. C. (1993) · Genetics · doi:10.1093/genetics/135.1.205 · Cited by 850 · see citing works

Hyaluronan Synthases

Weigel, P. H., Hascall, V., & Tammi, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.13997 · Cited by 629 · see citing works

Experimental strategies for the genetic dissection of complex traits in animal models

Darvasi, A. (1998) · Nature Genetics · doi:10.1038/ng0198-19 · Cited by 540 · see citing works

Matrix as a Modulator of Hepatic Fibrogenesis

Schuppan, D., Ruehl, M., Somasundaram, R., & Hahn, E. G. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17556 · Cited by 540 · see citing works

A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues

Jamall, I. S., Finelli, V. N., & Hee, S. S. Q. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90261-x · Cited by 522 · see citing works

Detecting marker-QTL linkage and estimating QTL gene effect and map location using a saturated genetic map.

Darvasi, A., Weinreb, A., Minke, V., Weller, J. I., & Soller, M. (1993) · Genetics · doi:10.1093/genetics/134.3.943 · Cited by 489 · see citing works

Overview of QTL mapping software and introduction to Map Manager QT

Manly, K. F., & Olson, J. M. (1999) · Mammalian Genome · doi:10.1007/s003359900997 · Cited by 448 · see citing works

Cytokine Receptors and Signaling in Hepatic Stellate Cells

Pinzani, M., & Marra, F. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17554 · Cited by 432 · see citing works

Selective genotyping for determination of linkage between a marker locus and a quantitative trait locus

Darvasi, A., & Soller, M. (1992) · Theoretical and Applied Genetics · doi:10.1007/bf00222881 · Cited by 410 · see citing works

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

Edwards-Smith, C. J., Jonsson, J. R., Purdie, D. M., Bansal, A. S., Shorthouse, C., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510300207 · Cited by 403 · see citing works

Host genetic factors influence disease progression in chronic hepatitis C

Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A. D., Crawford, D. H., Shorthouse, C., Purdie, D. M., & Jonsson, J. R. (2000) · Hepatology · doi:10.1053/he.2000.6253 · Cited by 397 · see citing works

Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma

Karp, C. L., Grupe, A., Schadt, E. E., Ewart, S., Keane-Moore, M., Cuomo, P. J., Köhl, J., Wahl, L. M., Kuperman, D. A., Germer, S., et al. (2000) · Nature Immunology · doi:10.1038/79759 · Cited by 378 · see citing works

Clustering of Hepatotoxins Based on Mechanism of Toxicity Using Gene Expression Profiles

Waring, J. F., Jolly, R. A., Ciurlionis, R., Lum, P. Y., Præstgaard, J., Morfitt, D. C., Buratto, B., Roberts, C., Schadt, E. E., & Ulrich, R. G. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9243 · Cited by 376 · see citing works

The C5a chemoattractant receptor mediates mucosal defence to infection

Höpken, U. E., Lu, B., Gerard, N. P., & Gerard, C. J. (1996) · Nature · doi:10.1038/383086a0 · Cited by 344 · see citing works

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

Shi, Z., Wakil, A. E., & Rockey, D. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10663 · Cited by 310 · see citing works

Statistical Methods for Mapping Quantitative Trait Loci From a Dense Set of Markers

Dupuis, J., & Siegmund, D. (1999) · Genetics · doi:10.1093/genetics/151.1.373 · Cited by 299 · see citing works

In Silico Mapping of Complex Disease-Related Traits in Mice

Grupe, A., Germer, S., Usuka, J., Aud, D., Belknap, J. K., Klein, R. F., Ahluwalia, M. K., Higuchi, R., & Peltz, G. (2001) · Science · doi:10.1126/science.1058889 · Cited by 285 · see citing works

Experimental Models of Hepatic Fibrosis: A Review

Tsukamoto, H., Matsuoka, M., & French, S. W. (1990) · Seminars in Liver Disease · doi:10.1055/s-2008-1040457 · Cited by 272 · see citing works

Cytokines in the liver

Ramadori, G. P., & Armbrust, T. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200107000-00004 · Cited by 231 · see citing works

Rna Expression in the Early Characterization of Hepatotoxicants in Wistar Rats by High–Density Dna Microarrays

Bulera, S. J., Eddy, S. M., Ferguson, E., Jatkoe, T. A., Reindel, J. F., Bleavins, M. R., & de la Iglesia, F. A. (2001) · Hepatology · doi:10.1053/jhep.2001.23560 · Cited by 182 · see citing works

CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis

Agarwal, K., Jones, D. E. J., Daly, A. K., James, O., Vaidya, B., Pearce, S. H. S., & Bassendine, M. F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80213-5 · Cited by 176 · see citing works

Studies of Murine Schistosomiasis Reveal Interleukin–13 Blockade As A Treatment for Established and Progressive Liver Fibrosis

Chiaramonte, M. G., Cheever, A. W., Malley, J. D., Donaldson, D. D., & Wynn, T. A. (2001) · Hepatology · doi:10.1053/jhep.2001.26376 · Cited by 175 · see citing works

A miracle enough: the power of mice

Paigen, K. (1995) · Nature Medicine · doi:10.1038/nm0395-215 · Cited by 170 · see citing works

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

Grove, J., Daly, A. K., Bassendine, M. F., Gilvarry, E., & Day, C. P. (2000) · Gut · doi:10.1136/gut.46.4.540 · Cited by 166 · see citing works

Reactivation of herpes simplex virus type 1 in patients with Bell's palsy

Furuta, Y., Fukuda, S., Chida, E., Takasu, T., Ohtani, F., Inuyama, Y., & Nagashima, K. (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199803)54:3 · Cited by 163 · see citing works

Hyaluronan is not just a goo!

Toole, B. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10706 · Cited by 161 · see citing works

Unique Gene Expression Patterns in Liver and Kidney Associated with Exposure to Chemical Toxicants

Bartosiewicz, M. J., Jenkins, D., Penn, S. G., Emery, J., & Buckpitt, A. R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29613-0 · Cited by 133 · see citing works

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

Yee, L. J., Tang, J.-M., Herrera, J., Kaslow, R., & van Leeuwen, D. J. (2000) · Genes and Immunity · doi:10.1038/sj.gene.6363696 · Cited by 128 · see citing works

HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility

Donaldson, P. T., Agarwal, K., Craggs, A., Craig, W., James, O., & Jones, D. (2001) · Gut · doi:10.1136/gut.48.3.397 · Cited by 124 · see citing works

Regulation of Hepatic Fibrosis and Extracellular Matrix Genes by the Th Response: New Insight into the Role of Tissue Inhibitors of Matrix Metalloproteinases

Vaillant, B. D., Chiaramonte, M. G., Cheever, A. W., Soloway, P. D., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7017 · Cited by 123 · see citing works

Association of polymorphisms of the transforming growth factor-β1 gene with the rate of progression of HCV-induced liver fibrosis

Gewaltig, J., Mangasser-Stephan, K., Gartung, C., Biesterfeld, S., & Gressner, A. M. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00738-0 · Cited by 111 · see citing works

Irradiation-Induced Expression of Hyaluronan (HA) Synthase 2 and Hyaluronidase 2 Genes in Rat Lung Tissue Accompanies Active Turnover of HA and Induction of Types I and III Collagen Gene Expression

Li, Y., Rahmanian, M., Widström, C., Lepperdinger, G., Frost, G. I., & Heldin, P. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.3.4102 · Cited by 95 · see citing works

Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region.

Gordon, M. A., Oppenheim, E., Camp, N. J., di Giovine, F., Duff, G. W., & Gleeson, D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80220-7 · Cited by 79 · see citing works

Serum hyaluronan - a non-invasive test for diagnosing liver cirrhosis

Plevris, J. N., Haydon, G. H., Simpson, K. J., Dawkes, R. M., Ludlum, C. A., Harrison, D. J., & Hayes, P. C. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012100-00009 · Cited by 76 · see citing works

Microcharacterization of Proteins

Lottspeich, F., & Kellner, R. (1999) · doi:10.1002/9783527613960.ch01 · Cited by 71 · see citing works

Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis

Jones, D. E. J., Watt, F. E., Grove, J. I., Newton, J. L., Daly, A. K., Gregory, W. L., Day, C. P., James, O., & Bassendine, M. F. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80067-1 · Cited by 67 · see citing works

In Silico Mapping of Mouse Quantitative Trait Loci

Chesler, E. J., Rodriguez‐Zas, S. L., & Mogil, J. S. (2001) · Science · doi:10.1126/science.294.5551.2423a · Cited by 66 · see citing works

The tumor necrosis factor-α promoter correlates with progression of primary biliary cirrhosis

Tanaka, A., Quaranta, S., Mattalia, A., Coppel, R., Rosina, F., Manns, M., & Gershwin, M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80135-4 · Cited by 60 · see citing works

Cytokine regulation of schistosome-induced granuloma and fibrosis

Wahl, S. M., Frazier-Jessen, M. R., Jin, W., Kopp, J. B., Sher, A., & Cheever, A. W. (1997) · Kidney International · doi:10.1038/ki.1997.187 · Cited by 60 · see citing works

The virtuosity of hepatic stellate cells

Friedman, S. L. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70413-0 · Cited by 55 · see citing works

Low-molecular-weight hyaluronic acid induces nuclear factor-κB-dependent resistance against tumor necrosis factor α-mediated liver injury in mice

Wolf, D. G. F., Schümann, J., Koerber, K., Kiemer, A. K., Vollmar, A. M., Sass, G., Papadopoulos, T., Bang, R., Klein, S. D., Brüne, B., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.27218 · Cited by 53 · see citing works

Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: Mediation by interleukin-6 from Kupffer cells

Koleva, M., Schlaf, G., Landmann, R. M., Götze, O., Jungermann, K. A., & Schieferdecker, H. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.31883 · Cited by 40 · see citing works

NOMENCLATURE

Maltais, L. J., Blake, J. A., Eppig, J. T., & Davisson, M. T. (1997) · Genomics · doi:10.1006/geno.1997.5010 · Cited by 32 · see citing works

α-Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration

Jin, D. K., Vacher, J., & Feuerman, M. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8767 · Cited by 29 · see citing works

Complementing asthma

Henson, P. M. (2000) · Nature Immunology · doi:10.1038/79723 · Cited by 16 · see citing works

Light microscopic distinction of collagens in hepatic cirrhosis

Waldrop, F. S., & Puchtler, H. (1982) · Histochemistry and Cell Biology · doi:10.1007/bf00496662 · Cited by 13 · see citing works

Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1™ analyzer

Ropers, T., Kroll, W., Becka, M., Voelker, M., Burchardt, E. R., Schuppan, D., & Gehrmann, M. (2000) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00083-1 · Cited by 12 · see citing works

Amino Acid Analysis

Kellner, R., Meyer, H. E., & Lottspeich, F. (1999) · doi:10.1002/9783527613960.ch09 · Cited by 8 · see citing works

Cytokines in liver injury and repair

Gressner, A., Heinrich, P. C., & Matern, S. (2002) · Kluwer Academic Publishers eBooks · Cited by 7 · see citing works

Predictive Value of Cytokine Polymorphisms for Liver Disease

Donaldson, P., & Day, C. (2002) · Newcastle University ePrints (Newcastle Univesity) · doi:10.25405/ncl.34078665 · Cited by 1 · see citing works

Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications

Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 499 · see citing works

The carbon tetrachloride model in mice

Scholten, D., Trebicka, J., Liedtke, C., & Weiskirchen, R. (2015) · Laboratory Animals · doi:10.1177/0023677215571192 · Cited by 417 · see citing works

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects

Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K. L., Tacke, F., Tolba, R. H., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 336 · see citing works

Hepatic fibrosis: molecular mechanisms and drug targets

Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325 · see citing works

Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis

An, P., Wei, L.-L., Zhao, S., Sverdlov, D. Y., Vaid, K. A., Miyamoto, M., Kuramitsu, K., Lai, M., & Popov, Y. V. (2020) · Nature Communications · doi:10.1038/s41467-020-16092-0 · Cited by 319 · see citing works

Liver extracellular matrix in health and disease

Bédossa, P., & Paradis, V. (2003) · The Journal of Pathology · doi:10.1002/path.1397 · Cited by 304 · see citing works

Targeting Liver Fibrosis

Popov, Y. V., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23123 · Cited by 297 · see citing works

Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans

Hillebrandt, S., Wasmuth, H. E., Weiskirchen, R., Hellerbrand, C., Keppeler, H., Werth, A., Schirin-Sokhan, R., Wilkens, G., Geier, A., Lorenzen, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1599 · Cited by 258 · see citing works

Complement and viral pathogenesis

Burrack, K. S., & Morrison, T. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.045 · Cited by 256 · see citing works

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes

Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239 · see citing works

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells

Trebicka, J., Hennenberg, M., Odenthal, M., Shir, K., Klein, S., Granzow, M., Vogt, A., Dienes, H., Lammert, F., Reichen, J., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.025 · Cited by 228 · see citing works

Animal models of chronic liver diseases

Liu, Y., Meyer, C., Xu, C., Weng, H., Hellerbrand, C., ten Dijke, P., & Dooley, S. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2012 · Cited by 227 · see citing works

Animal models of NAFLD from a hepatologist's point of view.

Jahn, D., Kircher, S., Hermanns, H., & Geier, A. (2019) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.023 · Cited by 179 · see citing works

Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development

Delire, B., Stärkel, P., & Leclercq, I. A. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00035 · Cited by 171 · see citing works

Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice

Palacios, R. S., Roderfeld, M., Hemmann, S., Räth, T., Atanasova, S., Tschuschner, A., Gressner, O. A., Weiskirchen, R., Graf, J., & Roeb, E. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.91 · Cited by 170 · see citing works

Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans

Wasmuth, H. E., Lammert, F., Zaldivar, M. M., Weiskirchen, R., Hellerbrand, C., Scholten, D., Berres, M., Zimmermann, H. W., Streetz, K. L., Tacke, F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.053 · Cited by 168 · see citing works

Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases

Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H. H., Kubicka, S., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50268 · Cited by 165 · see citing works

The role of mouse strain differences in the susceptibility to fibrosis: a systematic review

Walkin, L., Herrick, S. E., Summers, A., Brenchley, P. E., Hoff, C. M., Korstanje, R., & Margetts, P. J. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-18 · Cited by 160 · see citing works

Spontaneous cholecysto- and hepatolithiasis in Mdr2 −/− mice: A model for low phospholipid-associated cholelithiasis†

Lammert, F., Wang, D. Q. ‐., Hillebrandt, S., Geier, A., Fickert, P., Trauner, M. A., Matern, S., Paigen, B. J., & Carey, M. C. (2004) · Hepatology · doi:10.1002/hep.20022 · Cited by 157 · see citing works

Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals

Brigstock, D. R. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0071-5 · Cited by 134 · see citing works

THE ROLE OF GENETIC POLYMORPHISMS IN ALCOHOLIC LIVER DISEASE

Stickel, F., & Österreicher, C. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl011 · Cited by 110 · see citing works

A New Mdr2−/− Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer

Ikenaga, N., Liu, S. B., Sverdlov, D., Yoshida, S., Nasser, I. A., Ke, Q., Kang, P. M., & Popov, Y. V. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.10.013 · Cited by 102 · see citing works

Strain dependence of diet‐induced <scp>NASH</scp> and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype

Farrell, G. C., Mridha, A. R., Yeh, M. M., Arsov, T., Van Rooyen, D. M., Brooling, J., Nguyen, T., Heydet, D., Delghingaro‐Augusto, V., Nolan, C. J., et al. (2014) · Liver International · doi:10.1111/liv.12335 · Cited by 85 · see citing works

Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer

Wei, G., An, P., Vaid, K. A., Nasser, I., Huang, P., Tan, L., Zhao, S., Schuppan, D., & Popov, Y. V. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2019 · Cited by 84 · see citing works

Complement Component 5 Mediates Development of Fibrosis, via Activation of Stellate Cells, in 2 Mouse Models of Chronic Pancreatitis

Sendler, M., Beyer, G., Mahajan, U. M., Kauschke, V., Maertin, S., Schurmann, C., Homuth, G., Völker, U., Völzke, H., Halangk, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.012 · Cited by 80 · see citing works

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies

Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 83 · see citing works

Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes # †

Tong, Z., Chen, R., Alt, D. S., Kemper, S., Perbal, B., & Brigstock, D. R. (2009) · Hepatology · doi:10.1002/hep.23102 · Cited by 78 · see citing works

Genome-wide association studies and genetic risk assessment of liver diseases

Krawczyk, M. J., Müllenbach, R., Weber, S. N., Zimmer, V., & Lammert, F. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.170 · Cited by 73 · see citing works

Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis

Undamatla, R., Fagunloye, O. G., Chen, J., Edmunds, L. R., Murali, A., Mills, A. S., Xie, B., Pangburn, M. M., SIPULA, I. J., Gibson, G. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34710-x · Cited by 69 · see citing works

Age and Ethnicity in Cirrhosis

Sajja, K. C., Mohan, D. P., & Rockey, D. C. (2014) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000106 · Cited by 67 · see citing works

Mouse Models of Liver Fibrosis

Ravichandra, A., & Schwabe, R. F. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_23 · Cited by 65 · see citing works

The potential role of genes in nonalcoholic fatty liver disease

Day, C. P. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.001 · Cited by 51 · see citing works

Effects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosis

Kim, K., Yang, H. J., Lee, J.-Y., Na, Y., Kwon, S.-Y., Kim, Y., Lee, J., & Jang, H.-J. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-363 · Cited by 48 · see citing works

Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1

Kornek, M., Raskopf, E., Gütgemann, I., Ocker, M., Gerceker, S., Gonzalez-Carmona, M. A., Rabe, C., Sauerbruch, T., & Schmitz, V. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.017 · Cited by 48 · see citing works

Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver Disease

Lad, A. C., Su, R. C., Breidenbach, J. D., Stemmer, P. M., Carruthers, N. J., Sanchez, N. M., Khalaf, F. K., Zhang, S., Kleinhenz, A. L., Dube, P. R., et al. (2019) · Toxins · doi:10.3390/toxins11090486 · Cited by 47 · see citing works

An Integrated in Silico Gene Mapping Strategy in Inbred Mice

Cervino, A., Darvasi, A., Fallahi, M., Mader, C. C., & Tsinoremas, N. F. (2006) · Genetics · doi:10.1534/genetics.106.065359 · Cited by 46 · see citing works

Animal models of portal hypertension

Königshofer, P., Brusilovskaya, K., Schwabl, P., & Reiberger, T. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.018 · Cited by 46 · see citing works

Interstrain differences in susceptibility to non‐alcoholic steatohepatitis

Yamazaki, Y., Kakizaki, S., Takizawa, D., Ichikawa, T., Sato, K., Takagi, H., & Mori, M. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05150.x · Cited by 46 · see citing works

Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis

Henkel, C., Roderfeld, M., Weiskirchen, R., Berres, M., Hillebrandt, S., Lammert, F., Meyer, H. E., Stühler, K., Graf, J., & Roeb, E. (2006) · PROTEOMICS · doi:10.1002/pmic.200600580 · Cited by 42 · see citing works

Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model

Haybaeck, J., Stumptner, C., Thueringer, A., Kolbe, T., Magin, T. M., Hesse, M., Fickert, P., Tsybrovskyy, O., Müller, H., Trauner, M. A., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.49 · Cited by 42 · see citing works

Hepatic Fibrosis and Cirrhosis

Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41 · see citing works

Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC

Roderfeld, M., Räth, T., Lammert, F., Dierkes, C., Graf, J., & Roeb, E. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i5.175 · Cited by 40 · see citing works

Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)

Miele, L., Forgione, A., Gasbarrini, A., & Grieco, A. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.011 · Cited by 38 · see citing works

Quantitative trait loci analysis of mice administered the methionine–choline deficient dietary model of experimental steatohepatitis

Rangnekar, A. S., Lammert, F., Igolnikov, A., & Green, R. M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01314.x · Cited by 38 · see citing works

Toll-Like Receptor 4–Independent Carbon Tetrachloride–Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice

Kumar, S., Wang, J., Shanmukhappa, S. K., & Gandhi, C. R. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.021 · Cited by 37 · see citing works

Genetic determinants of cholangiopathies: Molecular and systems genetics

Reichert, M., Hall, R. A., Krawczyk, M. J., & Lammert, F. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.029 · Cited by 37 · see citing works

Vitamin D modulates biliary fibrosis in ABCB4-deficient mice

Hochrath, K., Stokes, C. S., Geisel, J., Pollheimer, M. J., Fickert, P., Dooley, S., & Lammert, F. (2014) · Hepatology International · doi:10.1007/s12072-014-9548-2 · Cited by 36 · see citing works

Genetic Determinants in Hepatic Fibrosis: From Experimental Models to Fibrogenic Gene Signatures in Humans

Weber, S. N., Gressner, O. A., Hall, R. A., Grünhage, F., & Lammert, F. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.012 · Cited by 36 · see citing works

Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent*

Margetts, P. J., Hoff, C. M., Liu, L., Korstanje, R., Walkin, L., Summers, A., Herrick, S. E., & Brenchley, P. E. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs289 · Cited by 33 · see citing works

Preclinical insights into the gut‐skeletal muscle axis in chronic gastrointestinal diseases

Ehlers, L., Bannert, K., Rohde, S., Berlin, P., Reiner, J., Wiese, M. L., Doller, J., Lerch, M. M., Aghdassi, A. A., Meyer, F., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15554 · Cited by 31 · see citing works

TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver

Weber, S. N., Bohner, A., Dapito, D. H., Schwabe, R. F., & Lammert, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158819 · Cited by 30 · see citing works

Animal Models of Liver Diseases

Takahashi, Y., & Fukusato, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00013-9 · Cited by 28 · see citing works

The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice

Tuominen, I., Fuqua, B. K., Pan, C., Renaud, N., Wroblewski, K., Civelek, M., Clerkin, K., Asaryan, A., Haroutunian, S. G., Loureiro, J., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.08.010 · Cited by 28 · see citing works

Modeling hepatic osteodystrophy in Abcb4 deficient mice

Hochrath, K., Ehnert, S., Ackert‐Bicknell, C. L., Lau, Y., Schmid, A., Krawczyk, M. J., Hengstler, J. G., Dunn, J., Hiththetiya, K., Rathkolb, B., et al. (2013) · Bone · doi:10.1016/j.bone.2013.03.012 · Cited by 27 · see citing works

Cordyceps cicadae NTTU 868 mycelium prevents CCl 4 -induced hepatic fibrosis in BALB/c mice via inhibiting the expression of pro-inflammatory and pro-fibrotic cytokines

Ke, B.-J., & Lee, C.-L. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.02.010 · Cited by 25 · see citing works

The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis

Hochrath, K., Krawczyk, M. J., Goebel, R., Langhirt, M., Rathkolb, B., Micklich, K., Rozman, J., Horsch, M., Beckers, J., Klingenspor, M., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-209379 · Cited by 24 · see citing works

Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C

Vasel, M., Rutz, R., Bersch, C., Feick, P., Singer, M. V., Kirschfink, M., & Nakchbandi, I. A. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.11.014 · Cited by 24 · see citing works

Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood

Chen, S., Dong, Y., Qi, X., Cao, Q., Luo, T., Bai, Z., He, H., Fan, Z., Xu, L., Xing, G., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.011 · Cited by 23 · see citing works

A single-nucleus and spatial transcriptomic atlas of the COVID-19 liver reveals topological, functional, and regenerative organ disruption in patients

Pita-Juárez, Y. H., Karagkouni, D., Kalavros, N., Melms, J. C., Niezen, S., Delorey, T. M., Essene, A. L., Brook, O. R., Pant, D. B., Skelton-Badlani, D., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03499-5 · Cited by 21 · see citing works

Controlling Preanalytical Process in High-Coverage Quantitative Metabolomics: Spot-Sample Collection for Mouse Urine and Fecal Metabolome Profiling

Chen, D., Yu, J., Zhang, Z., Su, X., Li, L., & Li, L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00310 · Cited by 21 · see citing works

Systems Genetics of Liver Fibrosis: Identification of Fibrogenic and Expression Quantitative Trait Loci in the BXD Murine Reference Population

Hall, R. A., Liebe, R., Hochrath, K., Kazakov, A., Alberts, R., Laufs, U., Böhm, M., Fischer, H., Williams, R. W., Schughart, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089279 · Cited by 20 · see citing works

The therapeutic potential of exosomes derived from different cell sources in liver diseases

Pan, Y., Tan, W., Yang, M., Li, J., & Geller, D. A. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00054.2021 · Cited by 20 · see citing works

Mapping quantitative trait loci for proteinuria-induced renal collagen deposition

Kato, N., Watanabe, Y., Ohno, Y., Inoue, T., Kanno, Y., Suzuki, H., & Okada, H. (2008) · Kidney International · doi:10.1038/ki.2008.7 · Cited by 19 · see citing works

Hepatic Fibrosis and Cirrhosis

Rockey, D. C., & Friedman, S. L. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50011-5 · Cited by 19 · see citing works

Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis

Zehra, M., Curry, J. C., Pillai, S. S., Lakhani, H. V., Edwards, C. E., & Sodhi, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134737 · Cited by 17 · see citing works

Upregulation of fibronectin but not of entactin, collagen IV and smooth muscle actin by anaphylatoxin C5a in rat hepatic stellate cells.

Schlaf, G., Schmitz, M., Heine, I., Demberg, T., Schieferdecker, H. L., & Götze, O. (2004) · PubMed · doi:10.14670/hh-19.1165 · Cited by 18 · see citing works

Differential sensitivity of inbred mouse strains to ovarian damage in response to low-dose total body irradiation†

Quan, N., Harris, L. R., Halder, R., Trinidad, C. V., Johnson, B. W., Horton, S., Kimler, B. F., Pritchard, M. T., & Duncan, F. E. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz164 · Cited by 15 · see citing works

Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging

Müller, A., Hochrath, K., Stroeder, J., Hittatiya, K., Schneider, G. K., Lammert, F., Buecker, A., & Fries, P. (2017) · BioMed Research International · doi:10.1155/2017/8720367 · Cited by 15 · see citing works

Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder

Demaret, T., Roumain, M., Ambroise, J., Evraerts, J., Ravau, J., Bouzin, C., Bearzatto, B., Gala, J., Stepman, H. C. M., Marie, S., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165900 · Cited by 15 · see citing works

A Review of Liver Fibrosis and Emerging Therapies

Nathwani, R., Mullish, B. H., Kockerling, D., Forlano, R., Manousou, P., & Dhar, A. (2020) · European Medical Journal · doi:10.33590/emj/10310892 · Cited by 13 · see citing works

Genetic Studies to Identify Hepatic Fibrosis Genes and SNPs in Human Populations

Day, C. P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-940-0:315 · Cited by 14 · see citing works

Hepatic Fibrosis and Cirrhosis

Rockey, D. C., & Friedman, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00005-x · Cited by 13 · see citing works

Liver size and lipid content differences between BALB/c and BALB/cJ mice on a high-fat diet are due, in part, to Zhx2

Clinkenbeard, E. L., Turpin, C., Jiang, J., Peterson, M. L., & Spear, B. T. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09811-6 · Cited by 13 · see citing works

Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis

Semren, N., Habel, N., Fernandez, I. E., Königshoff, M., Eickelberg, O., Stöger, T., & Meiners, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136188 · Cited by 12 · see citing works

Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapy

Czekaj, P., Król, M., Limanówka, Ł., Michalik, M., Lorek, K., & Gramignoli, R. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172597 · Cited by 12 · see citing works

Mouse Model of Primary Biliary Cirrhosis With Progressive Fibrosis: Are We There Yet?

Popov, Y. V. (2012) · Hepatology · doi:10.1002/hep.25969 · Cited by 11 · see citing works

Genetische Risikofaktoren der Fibrogenese bei chronischen Lebererkrankungen*

Lammert, F., Matern, S., & Wasmuth, H. E. (2003) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-003-1324-3 · Cited by 10 · see citing works

Expression of the megalin C-terminal fragment by macrophages during liver fibrogenesis in mice

Pieper‐Fürst, U., Hall, R. A., Huss, S., Hochrath, K., Fischer, H., Tacke, F., Weiskirchen, R., & Lammert, F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.09.003 · Cited by 8 · see citing works

Liver fibrogenesis and genetic factors

Boursier, J., & Louvet, A. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(11)70002-x · Cited by 8 · see citing works

Systems Genetics of Liver Fibrosis

Hall, R. A., & Lammert, F. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6427-7_21 · Cited by 7 · see citing works

Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside

Ashmore‐Harris, C., Antonopoulou, E., Finney, S. M., Vieira, M. R., Hennessy, M. G., Münch, A., Lu, W., Gadd, V. L., Haj, A. J. E., Forbes, S. J., et al. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-024-00361-3 · Cited by 6 · see citing works

E96V Mutation in the Kdelr3 Gene Is Associated with Type 2 Diabetes Susceptibility in Obese NZO Mice

Altenhofen, D., Khuong, J. M.-A., Kuhn, T., Lebek, S., Görigk, S., Kaiser, K., Binsch, C., Grieß, K., Knebel, B., Belgardt, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010845 · Cited by 5 · see citing works

Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross

Hall, R. A., Hillebrandt, S., & Lammert, F. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9609-4 · Cited by 5 · see citing works

Peritoneal Membrane Injury and Peritoneal Dialysis

Chugh, S., Chaudhry, S., Ryan, T., & Margetts, P. J. (2014) · Advances in Nephrology · doi:10.1155/2014/573685 · Cited by 5 · see citing works

MicroRNAs as systemic biomarkers to assess distress in animal models for gastrointestinal diseases

Kumstel, S., Janssen‐Peters, H., Abdelrahman, A., Tang, G., Xiao, K., Ernst, N., Wendt, E. H. U., Palme, R., Seume, N., Vollmar, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73972-7 · Cited by 5 · see citing works

Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Liver Fibrosis

Chen, L., & Brigstock, D. R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6430-7_37 · Cited by 5 · see citing works

Systems genetics of hepatocellular damage in vivo and in vitro: identification of a critical network on chromosome 11 in mouse

Liebe, R., Hall, R. A., Williams, R. W., Dooley, S., & Lammert, F. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00078.2013 · Cited by 4 · see citing works

Usefulness of Non-Invasive Tools in Liver Fibrosis Assessment

Gutkowski, K., & Hartleb, M. (2008) · Hepatitis Monthly · Cited by 4 · see citing works

Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide

Poosti, F., Soebadi, M. A., Crijns, H., Zutter, A. D., Metzemaekers, M., Berghmans, N., Vanheule, V., Albersen, M., Opdenakker, G., Damme, J. V., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1370 · Cited by 3 · see citing works

Hjv mice in either C57BL/6 or AKR genetic background do not develop spontaneous liver fibrosis

Sgro, S., Wagner, J., Fillebeen, C., & Pantopoulos, K. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119747 · Cited by 2 · see citing works

Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice

Weber, S. N., Nowak, I., Grünhage, F., & Lammert, F. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101077 · Cited by 2 · see citing works

Preclinical approaches to studying liver and kidney fibrosis: models and methodologies

Tiwari, A., Singh, S., Sharma, R. K., & Kumar, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1718048 · Cited by 1 · see citing works

REGULATION OF HEPATIC GENE EXPRESSION DURING LIVER DEVELOPMENT AND DISEASE

Ren, H. (2012) · UKnowledge (University of Kentucky) · Cited by 1 · see citing works

A yellow bullet against the drivers of hepatic fibrogenesis†

Weiskirchen, R., Lammert, F., Kowdley, K. V., McCaughan, G., & Trautwein, C. (2008) · Hepatology · doi:10.1002/hep.22457 · Cited by 1 · see citing works

Drugs and the MousePharmacology, Pharmacogenetics, and Pharmacogenomics

Jorge-Nebert, L. F., Derkenne, S., & Nebert, D. W. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50028-5 · Cited by 1 · see citing works

INSIGHTS INTO HEPATIC ALPHA- FETOPROTEIN GENE REGULATION DURING LIVER DEVELOPMENT AND DISEASE

Clinkenbeard, E. L. (2012) · UKnowledge (University of Kentucky)

Genetics and Liver Diseases

Huang, H., Cheung, R. C., Donaldson, P. T., & Lammert, F. (2007) · doi:10.1002/9780470691861.ch3c

Power estimation for in silico mapping

Axenovich, T. I., & Zykovich, A. (2006) · Russian Journal of Genetics · doi:10.1134/s1022795406060160

BASIC-LIVER, PANCREAS, AND BILIARY TRACT Immune Stimulation of Hepatic Fibrogenesis by CD8 Cells and Attenuation by Transgenic Interleukin-10 From Hepatocytes

Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M. B., Mehal, W. Z., & Friedman, S. L. (2004)

The role of the coagulation system in the pathogenesis of liver injury

Dhar, A. (2011) · doi:10.25560/9479

Interacting QTLs for hepatic fibrosis in BALB/c and FVB/N strains of mice

Hillebrandt, S., Sauerbruch, T., & Lammert, F. (2006) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2006-950772

One and two QTL genome scans for liver fibrosis in inbred mice

Hall, R. A., Hillebrandt, S., Hochrath, K., Grünhage, F., Sauerbruch, T., & Lammert, F. (2007) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2007-967771

A susceptibility locus for hepatic fibrosis (Hepfib1) on chromosome 15 identified by genome-wide analysis in inbred mice

Hillebrandt, S., Matern, S., & Lammert, F. (2002) · RWTH Publications (RWTH Aachen)

Multiple quantitative trait loci modeling (MQM) of hepatic fibrosis in a murine intercross

Hall, R. A., & Lammert, F. (2015) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0035-1567965

Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross

Hall, R. A., Hillebrandt, S., & Lammert, F. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9609-4 · Cited by 5 · see citing works